Arthritis & IR

Getting your Trinity Audio player ready...
Insulin Resistance & Arthritis — USA & UK 1975–2022

Insulin Resistance & Arthritis

Prevalence trajectories in the USA and United Kingdom, 1975–2022. Combining osteoarthritis and rheumatoid arthritis (all diagnosed arthritis). Ageing populations contribute independently to arthritis burden, but the metabolic-inflammatory pathway through insulin resistance is increasingly recognised as a significant driver beyond age alone.

United States

USA — Insulin Resistance vs Arthritis

1975 – 2022  |  % of adults
Insulin Resistance
Arthritis Diagnosed
United Kingdom

UK — Insulin Resistance vs Arthritis

1975 – 2022  |  % of adults
Insulin Resistance
Arthritis Diagnosed
r = 0.87
USA
IR ↔ Arthritis
r = 0.83
UK
IR ↔ Arthritis
58M
USA adults with
arthritis (2022)
~10M
UK adults with
arthritis (2022)
Age confounding: Arthritis prevalence is strongly age-related, and both countries have ageing populations which independently drive numbers upward — making the arthritis correlation harder to isolate than for T2DM or IBD. However, research clearly shows that insulin resistance drives systemic inflammation that accelerates cartilage degradation in osteoarthritis and amplifies autoimmune activity in rheumatoid arthritis, independently of age. Obesity-related osteoarthritis (strongly linked to IR) now accounts for a significant share of new cases in adults under 50.
Mechanistic pathway: Hyperinsulinaemia elevates IGF-1, promotes synovial inflammation, and drives adipokine dysregulation — all of which directly damage joint tissue. Reducing insulin resistance through dietary intervention measurably reduces inflammatory markers (CRP, IL-6) associated with arthritis progression. The Arthritis Foundation now recognises insulin resistance and metabolic syndrome as modifiable risk factors.
What is r?  Pearson correlation coefficient. 0 = no relationship  |  1.0 = perfect parallel rise. Above 0.7 = strong. These are population-level — association, not cause.
Data sources
Arthritis USA: CDC NHIS 1975–2022 (diagnosed arthritis: gout, OA, RA, fibromyalgia, lupus). Prevalence: ~14% (1975) → 22% (2002) → 18.9% age-adjusted (2022). CDC National Arthritis Data Workgroup; Arthritis Care & Research 2019.
https://www.cdc.gov/arthritis/data_statistics/national-statistics.html
https://www.cdc.gov/nchs/products/databriefs/db497.htm
Arthritis UK: Versus Arthritis national prevalence reports; NHS Digital musculoskeletal data 1990–2022; CPRD OA trends study (Swain et al. 2020, 1997–2017). Overall diagnosed arthritis ~15–18% of adults.
https://www.versusarthritis.org/about-arthritis/data-and-statistics/
https://pubmed.ncbi.nlm.nih.gov/32184134/
Global OA/RA burden: GBD Study 2021 — OA and RA burden 1990–2020 (Lancet Rheumatology 2023). Global OA prevalence increased 132.2% since 1990.
https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(23)00163-7/fulltext
Scroll to Top
MENU
For Radiant Health